Skip Navigation LinksHome > April 2011 - Volume 18 - Issue 4 > Mechanisms of normal and abnormal endometrial bleeding
doi: 10.1097/gme.0b013e31820bf288
Special Section: Causality, Diagnosis & Management of Abnormal Uterine Bleeding

Mechanisms of normal and abnormal endometrial bleeding

Lockwood, Charles J. MD

Collapse Box


Expression of tissue factor (TF), the primary initiator of coagulation, is enhanced in decidualized human endometrial stromal cells (HESCs) during the progesterone-dominated luteal phase. Progesterone also augments a second HESC hemostatic factor, plasminogen activator inhibitor 1 (PAI-1). In contrast, progestins inhibit HESC matrix metalloproteinase (MMP) 1, 3, and 9 expression to stabilize endometrial stromal and vascular extracellular matrix. Through these mechanisms, decidualized endometrium is rendered both hemostatic and resistant to excess trophoblast invasion in the midluteal phase and throughout gestation to prevent hemorrhage and accreta. In nonfertile cycles, progesterone withdrawal results in decreased HESC TF and PAI-1 expression and increased MMP activity and inflammatory cytokine production promoting the controlled hemorrhage of menstruation and related tissue sloughing. In contrast to these well-ordered biochemical processes, unpredictable endometrial bleeding associated with anovulation reflects the absence of progestational effects on TF, PAI-1, and MMP activities as well as unrestrained angiogenesis rendering the endometrium nonhemostatic, proteolytic, and highly vascular. Abnormal bleeding associated with long-term progestin-only contraceptives results not from impaired hemostasis but from unrestrained angiogenesis leading to large, fragile endometrial vessels. This abnormal angiogenesis reflects the progestational inhibition of endometrial blood flow promoting local hypoxia and the generation of reactive oxygen species that increase the production of angiogenic factors such as vascular endothelial growth factor in HESCs and angiopoietin 2 in endometrial endothelial cells while decreasing HESC expression of angiostatic, angiopoietin 1. The resulting vessel fragility promotes bleeding. Aberrant angiogenesis also underlies abnormal bleeding associated with myomas and endometrial polyps; however, there are gaps in our understanding of this pathology.

©2011The North American Menopause Society


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.